Developing point-of-care CAR T manufacturing
European Pharmaceutical Review
DECEMBER 27, 2023
1 Following in vitro production from T cells collected from a patient’s leukapheresis procedure, the CAR T cells are infused back into the patient’s blood, where they proliferate and expand. This is in addition to its considerable price tag. Chimeric antigen receptor (CAR) T cells are the first example of a “living drug”.
85 
Let's personalize your content